Inventor · disambiguated record
Mark J. Suto
Also filed as: SUTO MARK J · SUTO MARK JAMES · SUTO Mark
65 granted patents·14 pending applications·1,019 citations·filing 1986–2024
99Inventor score
Top patents by PatentIndex Score
79 records- 0197US7615569B2Inhibitors of ion channelsICAGEN INC·Filed 2006·Granted Nov 10, 2009·58 cites·13 claims
- 0297US5177075ASubstituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and processWARNER LAMBERT CO·Filed 1991·Granted Jan 5, 1993·163 cites·8 claims
- 0393US5939421AQuinazoline analogs and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1997·Granted Aug 17, 1999·57 cites·25 claims
- 0491US5811428APyrimidine carboxamides and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1995·Granted Sep 22, 1998·69 cites·27 claims
- 0591US5420109ACytokine restraining agentsHOUGHTEN PHARM INC·Filed 1993·Granted May 30, 1995·84 cites·24 claims
- 0690US5935966APyrimidine carboxylates and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1997·Granted Aug 10, 1999·63 cites·24 claims
- 0790US4954515AHaloalkylaminomethyl-2-nitro-1H-imidazolesWARNER LAMBERT CO·Filed 1988·Granted Sep 4, 1990·28 cites·9 claims
- 0889US11623918B2Compounds for the treatment of acute and chronic kidney diseaseSOUTHERN RES INST·Filed 2021·Granted Apr 11, 2023·2 cites·19 claims
- 0988US11945781B2Compounds for the treatment of acute and chronic kidney diseaseSOUTHERN RES INST·Filed 2023·Granted Apr 2, 2024·1 cites·19 claims
- 1088US4806642APurine derivativesWARNER LAMBERT CO·Filed 1987·Granted Feb 21, 1989·25 cites·13 claims
- 1186US5786332ACytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levelsTREGA BIOSCIENCES INC·Filed 1995·Granted Jul 28, 1998·51 cites·46 claims
- 1286US5760001ACytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levelsTREGA BIOSCIENCES INC·Filed 1995·Granted Jun 2, 1998·52 cites·22 claims
- 1386US5098906APurine derivativesWARNER LAMBERT CO·Filed 1989·Granted Mar 24, 1992·22 cites·8 claims
- 1485US11447472B2Polymorophs of 5-aza-4′-thio-2′-deoxycytidineSOUTHERN RES INST·Filed 2021·Granted Sep 20, 2022·1 cites·22 claims
- 1585US4921859APurine derivativesWARNER LAMBERT CO·Filed 1988·Granted May 1, 1990·19 cites·22 claims
- 1684US10653682B2Oxadiazoles and thiadiazoles as TGF-β inhibitorsSOUTHERN RES INST·Filed 2018·Granted May 19, 2020·2 cites·23 claims
- 1783US11753374B2Compounds for the treatment of acute and chronic kidney diseaseSOUTHERN RES INST·Filed 2021·Granted Sep 12, 2023·1 cites·20 claims
- 1883US11524010B2Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitorsSOUTHERN RES INST·Filed 2021·Granted Dec 13, 2022·1 cites·24 claims
- 1983US5036096AAziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivativesWARNER LAMBERT CO·Filed 1990·Granted Jul 30, 1991·24 cites·7 claims
- 2083US4797397A2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cellsWARNER LAMBERT CO·Filed 1987·Granted Jan 10, 1989·32 cites·24 claims
- 2181US5726156ACytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levelsTREGA BIOSCIENCES INC·Filed 1995·Granted Mar 10, 1998·59 cites·31 claims
- 2280US11103508B2Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitorsSOUTHERN RES INST·Filed 2018·Granted Aug 31, 2021·2 cites·39 claims
- 2380US8063080B2Inhibitors of ion channelsFULP ALAN·Filed 2009·Granted Nov 22, 2011·6 cites·15 claims
- 2480US8034954B2Calcium channel antagonistsICAGEN INC·Filed 2006·Granted Oct 11, 2011·5 cites·24 claims
- 2580US5852028APyrimidine carboxylates and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1995·Granted Dec 22, 1998·29 cites·39 claims
- 2678US11046729B2Dipeptide analogs as TGF-beta inhibitorsSOUTHERN RES INST·Filed 2018·Granted Jun 29, 2021·1 cites·19 claims
- 2778US5072001ACertain optically active substituted 3-pyrraidine acetic acid derivatives useful as intermediatesWARNER LAMBERT CO·Filed 1990·Granted Dec 10, 1991·17 cites·4 claims
- 2877US10023579B2Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereofSOUTHERN RES INST·Filed 2016·Granted Jul 17, 2018·2 cites·30 claims
- 2977US6972287B1Method of inhibiting amyloid protein aggregation and imaging amyloid depositsPFIZER·Filed 2000·Granted Dec 6, 2005·10 cites·28 claims
- 3076US8431608B2Heterocycles as potassium channel modulatorsCHRISTOS THOMAS EUGENE·Filed 2010·Granted Apr 30, 2013·5 cites·13 claims
- 3176US7705158B2Inhibitors of ion channelsICAGEN INC·Filed 2006·Granted Apr 27, 2010·2 cites·31 claims
- 3276US5364861AOptical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agentsWARNER LAMBERT CO·Filed 1993·Granted Nov 15, 1994·15 cites·27 claims
- 3375US5116834AQuinolinecarboxylic acid antibacterial agentsWARNER LAMBERT CO·Filed 1991·Granted May 26, 1992·16 cites·13 claims
- 3475US2025082662A1Composition for treating blood cancer using 4'-thio-5-aza-2'-deoxycytidine and uses thereofSOUTHERN RES INST·Filed 2024·Application pending·0 cites
- 3574US4677219ASubstituted benzonitrilesWARNER LAMBERT CO·Filed 1986·Granted Jun 30, 1987·12 cites·4 claims
- 3673US10294235B2Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereofSOUTHERN RES INST·Filed 2018·Granted May 21, 2019·1 cites·16 claims
- 3773US2024174613A1Compounds for the Treatment Of Acute and Chronic Kidney DiseaseSOUTHERN RES INST·Filed 2024·Application pending·0 cites
- 3872US11905258B22-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseasesSOUTHERN RES INST·Filed 2022·Granted Feb 20, 2024·0 cites·13 claims
- 3972US11752153B2Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitorsSOUTHERN RES INST·Filed 2022·Granted Sep 12, 2023·0 cites·24 claims
- 4070US8058274B2Heterocycles as potassium channel modulatorsCHRISTOS THOMAS EUGENE·Filed 2008·Granted Nov 15, 2011·2 cites·29 claims
- 4170US5036089A2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agentsWARNER LAMBERT CO·Filed 1990·Granted Jul 30, 1991·11 cites·11 claims
- 4270US2023286933A12,5-aryl-thiazole analogs for the treatment of neurodegenerative diseasesSOUTHERN RES INST·Filed 2023·Application pending·0 cites
- 4368US5157128ACertain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediatesWARNER LAMBERT CO·Filed 1991·Granted Oct 20, 1992·8 cites·3 claims
- 4468US5073639AProcess for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agentsWARNER LAMBERT CO·Filed 1990·Granted Dec 17, 1991·10 cites·6 claims
- 4567US9018208B2Heterocycles as potassium channel modulatorsICAGEN INC·Filed 2013·Granted Apr 28, 2015·1 cites·9 claims
- 4667US8853250B2Sodium channel inhibitorsBEAUDOIN SERGE·Filed 2008·Granted Oct 7, 2014·1 cites·3 claims
- 4765US7297708B2Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligandsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 20, 2007·3 cites·8 claims
- 4864US6150372APyridopyrimidine analogs and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1999·Granted Nov 21, 2000·8 cites·25 claims
- 4963US12208112B2Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and uses thereofSOUTHERN RES INST·Filed 2021·Granted Jan 28, 2025·0 cites·10 claims
- 5063US11718593B22,5-aryl-thiazole analogs for the treatment of neurodegenerative diseasesSOUTHERN RES INST·Filed 2019·Granted Aug 8, 2023·0 cites·4 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark J. Suto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →